The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Research progress on paclitaxel nanoformulation
Author(s): 
Pages: 604-608
Year: Issue:  10
Journal: Qilu Pharmaceutical Affairs

Keyword:  紫杉醇纳米制剂靶向给药;
Abstract: 紫杉醇是微管抑制剂,临床用于治疗乳腺癌、卵巢癌等癌症的一线药物,溶解度较低为其临床应用带来诸多难题.纳米载体在药物递送中具有独特的优势,包括提高药物溶解度、增加药物循环时间、靶向运输至肿瘤部位、降低全身毒性等.本文综述了近几年紫杉醇纳米制剂的研究进展,为紫杉醇的进一步研究提供思路.
Related Articles
No related articles found